The PhRMA Foundation is more than a grantmaking body for early-career researchers; we are a community working together to advance the frontiers of innovation and discovery. Past awardee and current Foundation advisory committee member Jonathan Sockolosky, PhD, personifies the type of researcher that our organization seeks to support.
Hear advice from a former PhRMA Foundation Scientific Advisory Committee member on applying for research grants from the Foundation. Peter J. Neumann, ScD, director of the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center, will share his insight into writing a successful application for the Foundation's Value Assessment and Health Outcomes Research fellowships and grants.
Communicating research to the public benefits both researchers and society, but many scientists do not have adequate opportunities to receive science communications training. In this blog, learn 5 tips for writing a lay summary, a research description that uses clear, plain language for a public audience.
Are you a medical student or a physician interested in community-based clinical research? The PhRMA Foundation recently hosted an informational webinar about the Robert A. Winn Diversity in Clinical Trials Award Program, which supports early-stage investigator physicians and medical students to build a pipeline of community-oriented clinical trialists of diverse backgrounds.
The PhRMA Foundation congratulates our 2022 award recipients in the areas of drug delivery, drug discovery, translational medicine, health outcomes research, and value assessment.
Value Assessment Initiative
The PhRMA Foundation’s Value Assessment Initiative promotes the development of advanced value-assessment so decision makers have better tools to assess high- and low-value care in the U.S. health system. The initiative funds new research and innovative efforts to assess the value of medicines and health care services, improve patient outcomes and reduce inefficiency. Learn more.
Centers of Excellence in Value Assessment
Dr. Jessica Fortin researches small molecules that could inhibit one of the hallmarks of Alzheimer’s disease, the buildup of tangles of twisted proteins called tau. Dr. Fortin, an assistant professor of basic medical sciences, physiology, and pharmacology at the Purdue University College of Veterinary Medicine, told us about her work and what she hopes to accomplish in a Q&A for Alzheimer’s and Brain Awareness Month.
Amy M. Miller, PhD, Takes Helm of PhRMA Foundation
The PhRMA Foundation Board of Directors is pleased to name Amy M. Miller, PhD, as the new President of the Foundation.
Watch: Webinar Series on Patient-Centered Outcomes and Value Assessment
Content is now available online from the virtual three-part webinar series hosted by the PhRMA Foundation that focused on enhancing patient-centricity in value and health technology assessments.
Learn More About PhRMA Foundation Funding Opportunities
The PhRMA Foundation offers a wide variety of research grants, in categories ranging from predoctoral to postdoctoral and spanning several scientific disciplines. Check our awards page to learn more.